The impact of IMM-101 on Dendritic cells (I)

A collaboration between the laboratory of Prof. Andrew MacDonald at Manchester Collaborative Centre for Inflammation Research (University of Manchester, Manchester, UK) and Immodulon Therapeutics investigating the effects of IMM-101 (a heat-killed whole cell preparation of Mycobacterium obuense NCTC13365) has revealed far reaching immunological effects on dendritic cells, key players in both innate and adaptive immunity. Preliminary data were presented at the 2016 Keystone Symposium - Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies (J6).


Full title: The impact of Mycobacterium obuense (NCTC13365) on innate and adaptive immunity

Poster presented at the 2016 Keystone Symposium - Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies (J6) held in Vancouver (Canada).

Date: 24-28 January 2016

Author[s]: James Crooks, Sheila Brown, Laura Rosa Brunet and Andrew MacDonald


Click here to view the poster
Click here to view full abstract